Al Kaabi, N.; Yang, Y.; Eldin Hussein, S.; Yang, T.; Abdalla, J.; Wang, H.; Lou, Z.; Chinese Center for Disease Control and Prevention; Bakkour, A.; Arafat, A.;
et al. Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi. Vaccines 2023, 11, 299.
https://doi.org/10.3390/vaccines11020299
AMA Style
Al Kaabi N, Yang Y, Eldin Hussein S, Yang T, Abdalla J, Wang H, Lou Z, Chinese Center for Disease Control and Prevention, Bakkour A, Arafat A,
et al. Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi. Vaccines. 2023; 11(2):299.
https://doi.org/10.3390/vaccines11020299
Chicago/Turabian Style
Al Kaabi, Nawal, Yunkai Yang, Salah Eldin Hussein, Tian Yang, Jehad Abdalla, Hui Wang, Zhiyong Lou, Chinese Center for Disease Control and Prevention, Agyad Bakkour, Afnan Arafat,
and et al. 2023. "Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi" Vaccines 11, no. 2: 299.
https://doi.org/10.3390/vaccines11020299
APA Style
Al Kaabi, N., Yang, Y., Eldin Hussein, S., Yang, T., Abdalla, J., Wang, H., Lou, Z., Chinese Center for Disease Control and Prevention, Bakkour, A., Arafat, A., China National Biotec Group Company Limited, Jiang, Z., Tian, Y., National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd., Beijing Institute of Biological Products Company Limited, Xiao, P., Zaher, W., Eltantawy, I., Wang, C.,
... Yang, X.
(2023). Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi. Vaccines, 11(2), 299.
https://doi.org/10.3390/vaccines11020299
